%0 Journal Article
%A Chapiro, Elise
%A Pramil, Elodie
%A Diop, M'boyba
%A Roos-Weil, Damien
%A Dillard, Clémentine
%A Gabillaud, Clémentine
%A Maloum, Karim
%A Settegrana, Catherine
%A Baseggio, Lucile
%A Lesesve, Jean-François
%A Yon, Mélanie
%A Jondreville, Ludovic
%A Lesty, Claude
%A Davi, Frédéric
%A Le Garff-Tavernier, Magali
%A Droin, Nathalie
%A Dessen, Philippe
%A Algrin, Caroline
%A Leblond, Véronique
%A Gabarre, Jean
%A Bouzy, Simon
%A Eclache, Virginie
%A Gaillard, Baptiste
%A Callet-Bauchu, Evelyne
%A Muller, Marc
%A Lefebvre, Christine
%A Nadal, Nathalie
%A Ittel, Antoine
%A Struski, Stéphanie
%A Collonge-Rame, Marie-Agnès
%A Quilichini, Benoit
%A Fert-Ferrer, Sandra
%A Auger, Nathalie
%A Radford-Weiss, Isabelle
%A Wagner, Lena
%A Scheinost, Sebastian
%A Zenz, Thorsten
%A Susin, Santos A
%A Bernard, Olivier A
%A Nguyen-Khac, Florence
%T Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
%J Blood
%V 134
%N 21
%@ 1528-0020
%C Stanford, Calif.
%I HighWire Press
%M DKFZ-2020-00050
%P 1821-1831
%D 2019
%X B-cell prolymphocytic leukemia (B-PLL) is a rare hematological disorder whose underlying oncogenic mechanisms are poorly understood. Our cytogenetic and molecular assessments of 34 patients with B-PLL revealed several disease-specific features and potential therapeutic targets. The karyotype was complex (≥3 abnormalities) in 73
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:31527074
%R 10.1182/blood.2019001187
%U https://inrepo02.dkfz.de/record/148858